高级搜索
~(89)Sr治疗骨转移癌疼痛研究[J]. 肿瘤防治研究, 2003, 30(03): 233-235. DOI: 10.3971/j.issn.1000-8578.2713
引用本文: ~(89)Sr治疗骨转移癌疼痛研究[J]. 肿瘤防治研究, 2003, 30(03): 233-235. DOI: 10.3971/j.issn.1000-8578.2713
A study on pain relief of malignant bone metastasis with ~(89)Sr radionuclide therapy[J]. Cancer Research on Prevention and Treatment, 2003, 30(03): 233-235. DOI: 10.3971/j.issn.1000-8578.2713
Citation: A study on pain relief of malignant bone metastasis with ~(89)Sr radionuclide therapy[J]. Cancer Research on Prevention and Treatment, 2003, 30(03): 233-235. DOI: 10.3971/j.issn.1000-8578.2713

~(89)Sr治疗骨转移癌疼痛研究

A study on pain relief of malignant bone metastasis with ~(89)Sr radionuclide therapy

  • 摘要: 目的 评价放射性核素89锶 (89Sr)对骨转移癌的止痛疗效和不良反应, 并探讨其在癌性骨痛治疗中的应用范围。方法 观察 35例骨转移癌患者使用89Sr治疗后的止痛疗效、肿瘤标记物水平的变化、不良反应及血液学毒副反应。结果 89Sr止痛总有效率为 71 .4 %, 其中来源于前列腺癌和乳腺癌的骨转移癌患者有效率达到 80 .0 %。少数肿瘤标记物水平有下降。副反应主要为轻度可逆性的骨髓造血功能损害。89Sr对血生化无明显不良影响。结论 89Sr是治疗骨转移癌疼痛的一种安全有效的方法

     

    Abstract: Objective The aims were to evaluate the effectiveness of pain relief and toxicity of the 89 Sr radionuclide therapy for bone metastatic cancer and preliminarily determine the indication for pain relief of malignant bone metastasis. Methods The effect of pain relief, the level of tumor markers and the side effects of 35 cases of bone metastatic cancer were observed. The blood routine and blood biochemistry were tested. Results The total response rate was 71.4%, while the response rate of bon...

     

/

返回文章
返回